Concepedia

Karissa Finke

KF

Statistics

Publications

8

Citations

486

H-Index

8

Active since

2016

Affiliations

University of Kansas Medical Center(Current)

The University of Kansas Cancer Center

Icahn School of Medicine at Mount Sinai

University of Nebraska at Kearney

University of California, San Francisco

Karissa Finke is an author at University of Kansas Medical Center specializing in chemotherapy, pharmacology, and medicine.

Publications per year

2016–2022

8

Publications

8

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

, , +17

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Priyanka Sharma, Vandana G. Abramson, Anne O’Dea et al. · Clinical Cancer Research · 2021 · 85 citations · Full text

, , +17

Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)

Huan‐Chieh Chien, Claire Colas, Karissa Finke et al. · Journal of Medicinal Chemistry · 2018 · 81 citations · Full text

, , +17

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Rachel Yoder, Bruce F. Kimler, Joshua M. Staley et al. · npj Breast Cancer · 2022 · 74 citations · Full text

, , +13

LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs

Evan Augustyn, Karissa Finke, Arik A. Zur et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 47 citations · Full text

, , +8

1–5 of 8